Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I would think other countries around the world would be very interested in having a drug that can keep their population healthy. I understand that is not the case with FDA and medical a lot of the times here in the US curing people is a bad thing. Other countries don't have the ability to just print money out of thin air like US so the need their population healthy and working because they actually have to produce things and sell them throughout the world for their GDP and not just be huge consumers like US. You would think with all the testing that other countries regulators like our FDA would like to approve a drug like this for example the EMA. Or does the FDA have so much influence around the world that the other agencies around the world just side with FDA.
Interesting vaccine info.
Worse Than the Disease? Unintended Consequences of the mRNA Vaccines Against COVID-19
Share on facebookTweet on twitter
International Journal of Vaccine Theory, Practice & Research:
NOTE – This is a very long & very technical article. Here we give the ABSTRACT, a table of “Unprecedented” issues with the current COVID vaccines, and then titles and snippets from selected major sections of the article itself.
If you have time to read just ONE thing, scroll down to the “Unprecedented” table shown below.
ABSTRACT
Operation Warp Speed brought to market in the United States two mRNA vaccines, produced by Pfizer and Moderna. Interim data suggested high efficacy for both of these vaccines, which helped legitimize Emergency Use Authorization (EUA) by the FDA. However, the exceptionally rapid movement of these vaccines through controlled trials and into mass deployment raises multiple safety concerns.
In this review we first describe the technology underlying these vaccines in detail. We then review both components of and the intended biological response to these vaccines, including production of the spike protein itself, and their potential relationship to a wide range of both acute and long-term induced pathologies, such as blood disorders, neurodegenerative diseases and autoimmune diseases.
Among these potential induced pathologies, we discuss the relevance of prion-protein-related amino acid sequences within the spike protein. NOTE – “Prion” based diseases include Mad Cow disease in animals and Creutzfeldt-Jacob disease in humans.
We also present a brief review of studies supporting the potential for spike protein “shedding”, transmission of the protein from a vaccinated to an unvaccinated person, resulting in symptoms induced in the latter. NOTE – This phenomenon is sometimes referred to, optimistically, as a “self-spreading vaccine”.
We finish by addressing a common point of debate, namely, whether or not these vaccines could modify the DNA of those receiving the vaccination. While there are no studies demonstrating definitively that this is happening, we provide a plausible scenario, supported by previously established pathways for transformation and transport of genetic material, whereby injected mRNA could ultimately be incorporated into germ cell DNA for transgenerational transmission.
We conclude with our recommendations regarding surveillance that will help to clarify the long-term effects of these experimental drugs and allow us to better assess the true risk/benefit ratio of these novel technologies.
Unprecedented
Unprecedented. This word has defined so much about 2020 and the pandemic related to SARS-CoV-2. In addition to an unprecedented disease and its global response, COVID-19 also initiated an unprecedented process of vaccine research, production, testing, and public distribution (Shaw,2021).
The sense of urgency around combatting the virus led to the creation, in March 2020, of Operation Warp Speed (OWS), then-President Donald Trump’s program to bring a vaccine against COVID-19 to market as quickly as possible(Jacobs and Armstrong, 2020).
OWS established a few more unprecedented aspects of COVID-19. First, it brought the US Department of Defense into direct collaboration with US health departments with respect to vaccine distribution (Bonsell, 2021).
Second, the National Institutes of Health (NIH) collaborated with the biotechnology company Moderna in bringing an unprecedented type of vaccine against infectious disease to market, one utilizing a technology based on messenger RNA (mRNA) (National Institutes of Health, 2020).
The confluence of these unprecedented events has rapidly brought to public awareness the promise and potential of mRNA vaccines as a new weapon against infectious diseases into the future.
At the same time, events without precedent are, by definition, without a history and context against which to fully assess risks, hoped-for benefits, safety, and long-term viability as a positive contribution to public health.
In this paper we will be briefly reviewing oneparticular aspect of these unprecedented events, namely the development and deployment of mRNA vaccines against the targeted class of infectious diseases under the umbrella of “SARS-CoV-2.”
We believe many of the issues we raise here will be applicable toany future mRNA vaccine that might be produced against other infectious agents, or in applications related to cancer and genetic diseases, while others seem specifically relevant to mRNA vaccines currently being implemented against the subclass of corona viruses. While the promises of this technology have been widely heralded, the objectively assessed risks and safety concerns have received far less detailed attention. It is our intention to review several highly concerning molecular aspects of infectious disease-related mRNA technology, and to correlate these with both documented and potential pathological effects.
Vaccine Development
Development of mRNA vaccines against infectious disease is unprecedented in many ways. In a 2018 publication sponsored by the Bill and Melinda Gates Foundation, vaccines were divided into three categories: Simple, Complex, and Unprecedented (Young et al., 2018) …
Technology of mRNA Vaccines
In the early phase of nucleotide-based gene therapy development, there was considerably more effort invested in gene delivery through DNA plasmids rather than through mRNA technology. Two major obstacles for mRNA are its transient nature due to its susceptibility to breakdown by RNAses, as well as its known power to invoke a strong immune response, which interferes with its transcription into protein …
Adjuvants, Polyethylene Glycol, and Anaphylaxis
Adjuvants are vaccine additives intended to “elicit distinctive immunological profiles with regard to the direction, duration, and strength of immune responses” from the vaccines to which they are added (Liang et al., 2020). Alum or other aluminum compounds are most commonly utilized in traditional vaccines, and they elicit a wide range of systemic immune activation pathways as well as stromal cell activation at the site of the injection (Lambrecht et al., 2009; Danielsson & Eriksson, 2021) …
mRNA Vaccines, Spike Proteins, and Antibody-Dependent Enhancement (ADE)
ADE is an immunological phenomenon first described in 1964 (Hawkes et al., 1964). In that publication Hawkes described a set of experiments in which cultures of flavivirus were incubated with avian sera containing high titers of antibodies against those viruses. The unexpected finding was that, with increasingly high dilutions of the antibody-containing sera, cell infectivity was enhanced …
Pathogenic Priming, Multisystem Inflammatory Disease, and Autoimmunity
Pathogenic priming is a concept that is similar in outcome to ADE, but different in the underlying mechanism. We discuss it here as a unique mechanism through which the mRNA vaccines could provoke associated pathologies. In April 2020 an important paper was published regarding the potential for self-reactive antibodies to be generated following exposure to the spike protein and other antigenic epitopes spread over the length of SARS-CoV-2 ….
The Spleen, Platelets and Thrombocytopenia
Dr. Gregory Michael, an obstetrician in Miami Beach, died of a cerebral hemorrhage 16 days after receiving the first dose of the Pfizer/BioNTech COVID-19 vaccine. Within three days of the vaccine, he developed idiopathic thrombocytopenic purpura (ITP), an autoimmune disorder in which the immune cells attack and destroy the platelets …
Spike Protein Toxicity
The picture is now emerging that SARS-CoV-2 has serious effects on the vasculature in multiple organs, including the brain vasculature … In a series of papers, Yuichiro Suzuki in collaboration with other authors presented a strong argument that the spike protein by itself (with NO VIRUS ATTACHED) an cause a signaling response in the vasculature with potentially widespread consequences (Suzuki, 2020; Suzuki et al., 2020; Suzuki et al., 2021; Suzuki and Gychka, 2021) …
A Possible Link to Prion Diseases and Neurodegeneration
Prion diseases are a collection of neurodegenerative diseases that are induced through the misfolding of important bodily proteins, which form toxic oligomers that eventually precipitate out as fibrils causing widespread damage to neurons…The CDC web site on prion diseases states that “prion diseases are usually rapidly progressive and always fatal.”(Centers for Disease Control and Prevention, 2018).
This was written last year 2020 by completely different doctor before any variant existed saying what this doctor was saying. Explained very well in this article. Written august 2020. B is the answer has always been the answer.
https://sciencewithdrdoug.com/2020/08/01/is-a-coronavirus-vaccine-a-ticking-time-bomb/
This video is of the doctor that created messenger RNA vaccines. It’s worth listening to all 10 minutes but especially the last minute I think that is where our drug comes in to play.
https://www.bitchute.com/video/6UUAzpCGtKfB/
Going to be a fun ride with this stock. Great CEO, unlimited upside and when price drops company is buying those shares making our stock stronger in the future. Will be back Sept 1 with at least triple the value as now.
There is absolutely no doubt the right man is running the show for this company. All of those people talking about selling tomorrow I am sure that will make henry happy because he will have someone picking up those shares getting us closer to the 25 billion buy back by the end of the year.
It’s better to go a little slower and get everything done right which is what Henry is doing. He was not obligated to tell us that it was going to be delayed a few weeks, that says a lot about the person running the company. Making sure that all of the reports are filed accurately is very important right now before this stock really takes off. I am sure in the future as the company grows he will bring on a much bigger firm. New people coming on have a great opportunity to start buying now and in A month or to start seeing returns.
Thank you very much for explanation
Could someone explain about the shares that individuals will receive from the other company on the 20 to 1 exchange? Will the shares that we receive have any initial value?
I dont think Leo will put out any results or give updates on testing as far as effectiveness til after trial is completed. I feel everything that comes out about trial at this point has to be reviewed by FDA first since our trial is under the FDA. Leo's hands will be tied on what he can say until after everything is completed. Just my opinion. Not going to be any everything seems to be going very well half way through the trial.
This is best explanation I have seen about vaccines and how they work.
https://rumble.com/vfd0s1-what-they-dont-tell-you-about-the-vaccines.html
A question for the people on the board and thank you for any input. . If we were not in a pandemic right now and we were developing our drug for the pan coronavirus treatments for the future( Using the exact time frame that we started last year for the COVID-19) would we be farther along in the process or less far at this point? Would the company have spent more money or less money getting the same research done to be where we are today?
I find it very interesting that none of these messenger RNA vaccines have ever passed animal testing. Maybe I am wrong somebody show me differently?
Haven’t seen his name mentioned in a while, but I’m sure Dr. Degrado is pretty Excited and very busy right now.
Only you can decide that after doing your own DD. Best of luck. It might be a good idea to buy 900,000 and then buy me 100,000 LOL.
Well according to people on this board all this shares being sold for financing the people that buy them like Mako etc are just selling them all the time so they don’t own anything
Lemon how are people getting 30 percent for 10 million?
Lemon how are people getting 30 percent for 10 million?
Flipping is going to lead to chasing.
Kip Bay here to stay for a while. They can’t be wished away. MMs. And others in full panic mode. Imagine the panic when B is the solution.
I’m sensing nervous wishful thinking is on board today. Must have sold at 8 cents
Things unfolding very nicely here for longs. Leo executing plan nicely.
Interesting thoughts LOL. The Russian mafia bought into a stock that we know will work against the virus, But the government and head of CDC for monetary reasons pushed and approved a drug for treatment of virus that we all knew would not work while knowing a better drug was out there. So who would be more corrupt lol
Interesting. Funny easy to see the excitement and nervousness on the same board.
Great reminder Attila. I did that Earlier this year but it was at $.40 so congratulations on getting to do that at $.15. As I stated in my earlier post it was someone from this board that mentioned that to me and I was able to do it without them telling me this I would have never known. Another way that I have benefited from posters.
Over the coming months it will be very interesting because Everybody will be buying including the shorts. What is more valuable a vaccine that will work 60% of the time against a specific virus or a therapeutic that will work 90% of the time against This virus and other ones to come in the future? Pretty easy to answer. Imagine how much a company like Pfizer would be making right now if they owned our drug.
This stock is being built with science and hard work by Leo, Dr Degrado and others at the corporate level. Obviously all of his decisions have not been correct but I think his intent has always been to do what is best for the company which will be what is best for the shareholders. I think after successful trials in a few years people will look back and see just what a great job that he did with everything stacked against him by those who do not play by the rules. Also a lot of great posters doing their due diligence keeping people informed and promoting the stock through thick and thin will pay off for all shareholders.We all know who these posters are that I’ve done such a great job and I think I can speak for most everyone except for a few that we are very grateful for the work that they have put in to keep us informed and updated. Looking forward to some great days for the stock and wishing everyone the best for financial and personal success as a result of IPIX and patience. For new people coming onboard, buy what you can and take enough profit to get back what you have invested and then let the rest ride. Set your GTC at 30 plus dollars and in a few years or earlier your life will be much easier and you will be able to do more for your family and friends. Long for 3 years and 5 months
The only people that would be hoping this test is not successful as those who have so much money to lose that they don’t even want something out there to help people with the virus. It says a lot about a person who would be rooting against a good test results.
Just found out friend tested positive today and was supposed to get the second shot in 6 days
It would be interesting to know that after people are receiving vaccines are they told to continue to wear mask?
Dp I guess you just disproved the notion that the vaccine was not deadly.
Good things or should I say great things they are coming no matter what anybody post positive or negative it will not stop what is going to happen. That is a good thing for some and a bad thing for others. But one thing I can tell you for 100% sure no matter what is posted on this board it will happen. Pumping the stock or bashing the stock will not make What is going to happen go one second faster or one second slower but it is coming.
We have the answer and the FDA knows it.
https://www.yahoo.com/news/while-coronavirus-vaccines-race-ahead-124400366.html